Clinical Trial Update: Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on liposomal bupivacaine interscalene nerve block for shoulder arthroplasty; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shoulder Arthropathy

Drugs mentioned

• Bupivacaine Liposomal Injectable Suspension (bupivacaine liposomal injectable suspension)
• liposomal bupivacaine interscalene nerve block (liposomal bupivacaine)

Snippet

Sponsor: Mayo Clinic | Conditions: Arthropathy Shoulder | Phase 4 | Status: COMPLETED | Results posted: 2021-02-21